These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36460083)

  • 1. Preclinical development of an EP2 antagonist for post-seizure cognitive deficits.
    Varvel NH; Amaradhi R; Espinosa-Garcia C; Duddy S; Franklin R; Banik A; Alemán-Ruiz C; Blackmer-Raynolds L; Wang W; Honore T; Ganesh T; Dingledine R
    Neuropharmacology; 2023 Feb; 224():109356. PubMed ID: 36460083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.
    Jiang J; Yang MS; Quan Y; Gueorguieva P; Ganesh T; Dingledine R
    Neurobiol Dis; 2015 Apr; 76():126-136. PubMed ID: 25600211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus.
    Rojas A; Ganesh T; Lelutiu N; Gueorguieva P; Dingledine R
    Neuropharmacology; 2015 Jun; 93():15-27. PubMed ID: 25656476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status Epilepticus.
    Varvel NH; Espinosa-Garcia C; Hunter-Chang S; Chen D; Biegel A; Hsieh A; Blackmer-Raynolds L; Ganesh T; Dingledine R
    J Neurosci; 2021 Feb; 41(5):1105-1117. PubMed ID: 33293358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats.
    Rojas A; Amaradhi R; Banik A; Jiang C; Abreu-Melon J; Wang S; Dingledine R; Ganesh T
    Neurotherapeutics; 2021 Apr; 18(2):1207-1225. PubMed ID: 33410110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats.
    Rojas A; Ganesh T; Manji Z; O'neill T; Dingledine R
    Neuropharmacology; 2016 Nov; 110(Pt A):419-430. PubMed ID: 27477533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.
    Jiang J; Yu Y; Kinjo ER; Du Y; Nguyen HP; Dingledine R
    Neuropharmacology; 2019 May; 149():149-160. PubMed ID: 30763657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting prostaglandin receptor EP2 for adjunctive treatment of status epilepticus.
    Nagib MM; Yu Y; Jiang J
    Pharmacol Ther; 2020 May; 209():107504. PubMed ID: 32088247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.
    Rojas A; Ganesh T; Wang W; Wang J; Dingledine R
    Neurobiol Dis; 2020 Jan; 133():104399. PubMed ID: 30818067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.
    Jiang J; Ganesh T; Du Y; Quan Y; Serrano G; Qui M; Speigel I; Rojas A; Lelutiu N; Dingledine R
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3149-54. PubMed ID: 22323596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer's disease.
    Banik A; Amaradhi R; Lee D; Sau M; Wang W; Dingledine R; Ganesh T
    J Neuroinflammation; 2021 Nov; 18(1):273. PubMed ID: 34801055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.
    Jiang J; Quan Y; Ganesh T; Pouliot WA; Dudek FE; Dingledine R
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3591-6. PubMed ID: 23401547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EP2 receptor agonist ONO-AE1-259-01 attenuates pentylenetetrazole- and pilocarpine-induced seizures but causes hippocampal neurotoxicity.
    Santos AC; Temp FR; Marafiga JR; Pillat MM; Hessel AT; Ribeiro LR; Miyazato LG; Oliveira MS; Mello CF
    Epilepsy Behav; 2017 Aug; 73():180-188. PubMed ID: 28645087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EP2 Receptor Signaling Regulates Microglia Death.
    Fu Y; Yang MS; Jiang J; Ganesh T; Joe E; Dingledine R
    Mol Pharmacol; 2015 Jul; 88(1):161-70. PubMed ID: 25715797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.
    White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M
    Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats.
    Ma L; Cui XL; Wang Y; Li XW; Yang F; Wei D; Jiang W
    Brain Res; 2012 Aug; 1469():103-13. PubMed ID: 22765917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AH6809 decreases production of inflammatory mediators by PGE
    Li P; Jiang H; Wu H; Wu D; Li H; Yu J; Lai J
    Brain Res; 2018 Nov; 1698():11-28. PubMed ID: 29792868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype.
    Kang X; Qiu J; Li Q; Bell KA; Du Y; Jung DW; Lee JY; Hao J; Jiang J
    Sci Rep; 2017 Aug; 7(1):9459. PubMed ID: 28842681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COX-2/prostanoid signaling cascades in seizure disorders.
    Rojas A; Chen D; Ganesh T; Varvel NH; Dingledine R
    Expert Opin Ther Targets; 2019 Jan; 23(1):1-13. PubMed ID: 30484341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.
    van Vliet EA; Forte G; Holtman L; den Burger JC; Sinjewel A; de Vries HE; Aronica E; Gorter JA
    Epilepsia; 2012 Jul; 53(7):1254-63. PubMed ID: 22612226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.